Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Vincenzo De Geronimo"'
Autor:
Giuseppe Lisco, Olga Eugenia Disoteo, Vincenzo De Geronimo, Anna De Tullio, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Emilio Jirillo, Vincenzo Triggiani
Publikováno v:
Endocrines, Vol 5, Iss 1, Pp 72-86 (2024)
Background: Tirzepatide (TZP) is a once-weekly glucagon-like peptide 1 (GLP-1) and glucose-dependent-insulinotropic-polypeptide (GIP) receptor co-agonist approved for T2D. TZP provides promising evidence in improving glucose control and weight loss i
Externí odkaz:
https://doaj.org/article/cd4aec6ccfcc40fc8b15cb0ffd31880c
Autor:
Giuseppe Lisco, Anna De Tullio, Olga Disoteo, Giuseppina Piazzolla, Edoardo Guastamacchia, Carlo Sabbà, Vincenzo De Geronimo, Enrico Papini, Vincenzo Triggiani
Publikováno v:
Endocrine Connections, Vol 12, Iss 11, Pp 1-7 (2023)
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from retrospective cohort studies suggest that chronic exposure to GLP-1RAs in T2D may increase t
Externí odkaz:
https://doaj.org/article/bdc54c1d61ab4e9fb5d717056b3d2fc8
Autor:
Giuseppe Lisco, Anna De Tullio, Vincenzo De Geronimo, Vito Angelo Giagulli, Edoardo Guastamacchia, Giuseppina Piazzolla, Olga Eugenia Disoteo, Vincenzo Triggiani
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1852 (2024)
Background. One hundred years have passed since the discovery of insulin, which is one of the most relevant events of the 20th century. This period resulted in extraordinary progress in the development of novel molecules to improve glucose control, s
Externí odkaz:
https://doaj.org/article/d9697670e97c4efebed3746d2fb5480b
Autor:
Giuseppe Lisco, Anna De Tullio, Olga Disoteo, Vincenzo De Geronimo, Giuseppina Piazzolla, Giovanni De Pergola, Vito Angelo Giagulli, Emilio Jirillo, Edoardo Guastamacchia, Carlo Sabbà, Vincenzo Triggiani
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Tirzepatide, a dual agonist of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide 1 (GLP-1) receptors, improved glucose control and reduced body weight in different therapeutic approaches. Herein, we overviewed the role of G
Externí odkaz:
https://doaj.org/article/f07fd6da2bfb47639191c763674ac8fc
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:1954-1960
Background: Thyroid disease and obesity are very common clinical conditions in the general population. They can occur together in the same subject, but their relationship does not seem to be exclusively stochastic. Aim: We critically reviewed the evi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ef2a20030caca8b3eb347539b6f0bb
https://doi.org/10.2174/1871530321666210118162625
https://doi.org/10.2174/1871530321666210118162625
Autor:
Andrea Palermo, Alberto Falchetti, Fabio Vescini, Vincenzo De Geronimo, Alfredo Scillitani, Iacopo Chiodini, Luigi Gennari, Roberto Cesareo
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:577-585
Inadequate serum selenium levels may delay the growth and physiological changes in bone metabolism. In humans, reduced serum selenium concentrations are associated with both increased bone turnover and reduced bone mineral density. Moreover, a reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0d75cc239a5f253a81cec58d6ebb57
https://doi.org/10.2174/1871530320666200628030913
https://doi.org/10.2174/1871530320666200628030913
Autor:
Angelica Di Vincenzo, Sergio Castorina, Giovanni Lezoche, Tonia Luca, Antonio Giordano, Marina Taus, Ilaria Cosentini, Vincenzo De Geronimo, Daniele F. Condorelli, Vincenza Barresi, Giovanna Privitera, Saverio Cinti, Albano Nicolai, Giorgio Barbatelli
Publikováno v:
International Journal of Obesity. 45:184-194
Background/objectives Distribution and activity of ghrelin cells in the stomach of obese subjects are controversial. Subjects/methods We examined samples from stomachs removed by sleeve gastrectomy in 49 obese subjects (normoglycemic, hyperglycemic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca011fc309e776cc8d50f1081a13e0fb
https://doi.org/10.1038/s41366-020-00711-3
https://doi.org/10.1038/s41366-020-00711-3
Autor:
Simonetta Marucci, Yura Loscalzo, Marco Giannini, Vincenzo Triggiani, Giuseppe Lisco, Edoardo Guastamacchia, Vincenzo De Geronimo, P. Garofalo, Roberto Attanasio
Publikováno v:
Endocrine, metabolicimmune disorders drug targets. 21(12)
Background: Some endocrinologists were involved in the management of patients with suspected or confirmed COVID-19 during the first wave of the pandemic. This study aims to analyze burnout levels among the Association of Medical Endocrinologists (AME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebedbdf437e59e5eb008bf61af7d36d2
https://pubmed.ncbi.nlm.nih.gov/34303333
https://pubmed.ncbi.nlm.nih.gov/34303333
Autor:
Vincenzo De Geronimo
Publikováno v:
Thyroid, Obesity and Metabolism ISBN: 9783030802660
This chapter examines some inter-operative aspects of thyroid physiology and adipose tissue. There are also observational reports confirming (or not) the link between autoimmune thyroid disease, thyroid cancer, thyroid physiopathology, and obesity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8a374e1b8b9511137f3a2bca010d45a
https://doi.org/10.1007/978-3-030-80267-7_10
https://doi.org/10.1007/978-3-030-80267-7_10
